EarlySense Ltd.
14
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
42.9%
6 terminated/withdrawn out of 14 trials
40.0%
-46.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Evaluation of EarlySense for Monitoring Ovulation Cycles and Detection of Early Stages of Pregnancy in Home Environment
Role: lead
Accuracy Evaluation of EarlySense With Modified Sensor (Smaller Shape Sensor With BLE) at Home Setting Monitoring a Subject While Partner in Bed
Role: lead
Evaluation of Technologies for Neonates in Africa
Role: collaborator
Identifying At-Risk Patients and Predicting Deterioration of In-Patients Using Continuous Heart Rate, Respiratory Rate, and Movement Monitoring
Role: collaborator
Evaluation of EarlySense; a Contact-less Heart and Respiration Rate Monitoring in Sleep Lap Examined
Role: lead
Evaluation of EarlySense Home Care Tele-monitoring Device -For Early Detection of Deterioration For Cardiac Patients at Home
Role: lead
Evaluation of EverOn™ - A Contact-Free System for Measuring Heart Rate, Respiratory Rate and Motion
Role: lead
Monitoring Changes in Blood Pressure
Role: lead
EarlySense Monitoring Device Evaluation on CHF Patients
Role: lead
EarlySense Monitoring Device Evaluation on COPD, CHF and Pneumonia Patients
Role: lead
Eval EarlySense Bet Lowenstein Sleeplab
Role: lead
Monitoring of Nocturnal Hypoglycemia Using EarlySense Monitoring Device
Role: lead
Evaluation of EverOn™ System in Medical / Surgical Ward
Role: lead
Evaluation of EarlySense Home Care Tele-monitoring Device
Role: collaborator
All 14 trials loaded